These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31276165)

  • 1. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort.
    Sprockett D; Fischer N; Boneh RS; Turner D; Kierkus J; Sladek M; Escher JC; Wine E; Yerushalmi B; Dias JA; Shaoul R; Kori M; Snapper SB; Holmes S; Bousvaros A; Levine A; Relman DA
    Inflamm Bowel Dis; 2019 Nov; 25(12):1927-1938. PubMed ID: 31276165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.
    Levine A; Kori M; Kierkus J; Sigall Boneh R; Sladek M; Escher JC; Wine E; Yerushalmi B; Amil Dias J; Shaoul R; Veereman Wauters G; Boaz M; Abitbol G; Bousvaros A; Turner D
    Gut; 2019 Feb; 68(2):239-247. PubMed ID: 29420227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study.
    Verburgt CM; Dunn KA; Otley A; Heyman MB; Verstraete S; Sunseri W; Sylvester F; de Meij T; Comeau A; Langille M; de Jonge WJ; Benninga MA; Van Limbergen JE
    BMJ Open; 2023 Feb; 13(2):e064944. PubMed ID: 36725090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease.
    Levine A; Turner D
    J Crohns Colitis; 2011 Jun; 5(3):222-6. PubMed ID: 21575885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
    Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
    Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
    Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome.
    Jacobs JP; Goudarzi M; Lagishetty V; Li D; Mak T; Tong M; Ruegger P; Haritunians T; Landers C; Fleshner P; Vasiliauskas E; Ippoliti A; Melmed G; Shih D; Targan S; Borneman J; Fornace AJ; McGovern DPB; Braun J
    Genome Med; 2022 Aug; 14(1):91. PubMed ID: 35971134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for induction of remission in Crohn's disease.
    Limketkai BN; Akobeng AK; Gordon M; Adepoju AA
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD006634. PubMed ID: 32678465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the Subgingival Microbiota in Pediatric Crohn's Disease Studied Longitudinally in Discovery and Validation Cohorts.
    Kelsen J; Bittinger K; Pauly-Hubbard H; Posivak L; Grunberg S; Baldassano R; Lewis JD; Wu GD; Bushman FD
    Inflamm Bowel Dis; 2015 Dec; 21(12):2797-805. PubMed ID: 26288001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gut microbiota with post-operative clinical course in Crohn's disease.
    Dey N; Soergel DA; Repo S; Brenner SE
    BMC Gastroenterol; 2013 Aug; 13():131. PubMed ID: 23964800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
    J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Distinct Gut Microbiota Exists Within Crohn's Disease-Related Perianal Fistulae.
    Haac BE; Palmateer NC; Seaton ME; VanYPeren R; Fraser CM; Bafford AC
    J Surg Res; 2019 Oct; 242():118-128. PubMed ID: 31075656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease.
    Hart L; Farbod Y; Szamosi JC; Yamamoto M; Britz-McKibbin P; Halgren C; Zachos M; Pai N
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32517036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
    Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics in pediatric inflammatory bowel diseases: a systematic review.
    Verburgt CM; Heutink WP; Kuilboer LIM; Dickmann JD; van Etten-Jamaludin FS; Benninga MA; de Jonge WJ; Van Limbergen JE; Tabbers MM
    Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):891-908. PubMed ID: 34148466
    [No Abstract]   [Full Text] [Related]  

  • 20. Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease.
    Zhuang X; Tian Z; Feng R; Li M; Li T; Zhou G; Qiu Y; Chen B; He Y; Chen M; Zeng Z; Zhang S
    Inflamm Bowel Dis; 2020 Oct; 26(11):1636-1647. PubMed ID: 33026078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.